Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 78 citing Degenring: Intravitreal injection of triamcinolone acetonide as treatment for chronic uveitis. (0.10 sec) 

Intravitreal triamcinolone acetonide for exudative age related macular degeneration

- nih.gov - Free from Publisher
JB Jonas, I Kreissig, P Hugger, G Sauder, S … - British Journal of Ophthalmology, 2003 - bjo.bmj.com
Results: Visual acuity increased significantly (p <0.001) from 0.16 (0.11) to a
mean maximum of 0.23 (0.17). Postoperative visual acuity was highest 1–3
months after the injection. 47 (66.2%) eyes gained in maximal visual acuity ...
Cited by 530 - Related articles - BL Direct - All 11 versions

Intraocular pressure elevation after intravitreal triamcinolone acetonide injection

- occhioallaretina.it [PDF] 
JB Jonas, RF Degenring, I Kreissig, I … - Ophthalmology, 2005 - Elsevier
The study included 272 patients (305 eyes) receiving an intravitreal injection
of approximately 20 mg triamcinolone acetonide as treatment for diffuse diabetic
macular edema (n = 84 patients), exudative age-related macular degeneration ...
Cited by 165 - Related articles - All 4 versions

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and …


JB Jonas - Acta Ophthalmologica Scandinavica, 2005 - duanesolution.com
Cited by 89 - Related articles - Cached - BL Direct - All 5 versions

Intravitreal toxicity of the kenalog vehicle (benzyl alcohol) in rabbits


VL MORRISON, HJ KOH, L Cheng, K … - Retina, 2006 - journals.lww.com
Methods: Nine New Zealand rabbits were injected with either a control or a test
article at elevating concentrations. The test article was benzyl alcohol
calculated to give final injected concentrations of 0.0073%, 0.022%, ...
Cited by 74 - Related articles - BL Direct - All 5 versions

Branch retinal vein occlusion treated by intravitreal triamcinolone acetonide


JB Jonas, I Akkoyun, B Kamppeter, I Kreissig … - Eye, 2004 - nature.com
In the study group, mean visual acuity increased significantly (P=0.02) from
0.27 0.11 preoperatively to a best postoperative visual acuity of 0.45 0.27.
Visual acuity measurements determined 1 month after the injection were ...
Cited by 71 - Related articles - All 3 versions

Exudative age-related macular degeneration treated by intravitreal triamcinolone …


JB Jonas, RF Degenring, I Kreissig, T … - Eye, 2004 - nature.com
Visual acuity increased significantly (P=0.03) in the study group, and decreased
significantly (P=0.01) in the control group, at 1 month and 3 months after start
of the study. Between the study group and control group, the differences in ...
Cited by 56 - Related articles - All 3 versions

Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a …

- bmj.com [PDF] 
JB Jonas, I Akkoyun, I Kreissig, RF Degenring - British Medical Journal, 2005 - bjo.bmj.com
Diffuse diabetic macular oedema treated by intravitreal ... JB Jonas, I
Akkoyun, I Kreissig, RF Degenring ..............................................
............................................................................ ...
Cited by 55 - Related articles - All 8 versions

Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal …


TH Williamson, AO'Donnell - American journal of ophthalmology, 2005 - Elsevier
Mean duration of symptoms before surgery was 2 months (SD, 1.3 months). Ten
patients required repeated injections for recurrent cystoid macular edema (mean,
1.8 injections). Mean visual acuity significantly improved from 20/300 to ...
Cited by 54 - Related articles - All 18 versions

Intravitreal triamcinolone in the treatment of serous retinal detachment in Vogt-Koyanagi- …


RE Andrade, C Muccioli, ME Farah, RB … - American journal of ophthalmology, 2004 - Elsevier
Three eyes from two patients at the acute phase of Vogt-Koyanagi-Harada disease
with serous retinal detachments were treated with a 4-mg intravitreal injection
of triamcinolone acetonide. The following variables were evaluated: visual ...
Cited by 47 - Related articles - All 11 versions

Intravitreal triamcinolone acetonide: a change in a paradigm


JB Jonas - Ophthalmic Res, 2006 - content.karger.com
Background: Based on experimental studies and clinical observations by Robert
Machemer, Gholam Peyman and others, the vitreous cavity has increasingly been
used as a reservoir of drugs for the direct treatment of intraocular ...
Cited by 46 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google